|

Cyclosporine A (CsA) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • Federal Research Institute of Pediatric Hematology, Oncology and Immunology1

Indications

  • Acute Lymphoblastic Leukemia, Relapse1
  • Acute Myeloid Leukemia, High Risk1
  • Acute Lymphoblastic Leukemia, High Risk1
  • Acute Myeloid Leukemia, Relapsed1
  • Cancer1

Other1 trial

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.